Heather Raymon
SVP, Research and Development · Artiva Biotherapeutics, Inc.
- 2025
- May 20, 2026
- 5
Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies Heather Raymon files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- RA CAPITAL MANAGEMENT, L.P. - $117.62M in ARTV purchases and sales in the last 12 months
- GC Corp. - $16.50M in ARTV purchases and sales in the last 12 months
- Fred Aslan - $1.96M in ARTV purchases and sales in the last 12 months
- Christopher Horan - $249K in ARTV purchases and sales in the last 12 months
- Jennifer Bush - $230K in ARTV purchases and sales in the last 12 months
- Subhashis Banerjee - $187K in ARTV purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Heather Raymon?
Heather Raymon is a corporate insider, tracked as SVP, Research and Development of Artiva Biotherapeutics, Inc. (ARTV). InsiderAlpha holds 5 primary Form 4 filings for them, the earliest from 2025, updated as new SEC EDGAR filings are processed.
When did Heather Raymon last file a Form 4?
The most recent primary Form 4 on record is dated 20 May 2026, one of 5 filings going back to 2025.
Has Heather Raymon been buying or selling stock?
Recorded transactions: 0 open-market purchases and 1 open-market sale ($28K) across all tracked filings.
